September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum ultrasound system will be used during a live case following the International Contrast Ultrasound Society (ICUS) Bubbles Conference, Sept. 8-9 in Chicago. The demonstration is meant to show the benefits of the recent U.S. Food and Drug Administration (FDA) approval of ultrasound contrast for characterizing liver lesions in adults and pediatrics.
The live case will be performed on Saturday, Sept. 10 at Rush University Medical Center, Tower Procedure Lab in Chicago, between 9:30 a.m. and 1:30 p.m. CT.
“Toshiba’s Aplio 500 Platinum ultrasound offers a comprehensive and integrated technology package that allows clinicians to make diagnoses with confidence,” said Stephanie Wilson, M.D., ICUS co-president. “The system offers excellent resolution and image quality with a complete suite of tools to perform contrast-enhanced ultrasound, spectral and color Doppler or elastography. This allows clinicians to evaluate the entire patient.”
“Contrast-enhanced ultrasound provides clinicians with clearer images so they can diagnose accurately, which reduces the need for additional and expensive exams like CT [computed tomography] or MRIs [magnetic resonance imaging],” said Steven Feinstein, M.D., ICUS co-president. “There are long wait times to get a CT or MRI exam, and contrast-enhanced ultrasound imaging helps patients get a diagnosis faster, often within 24 hours.”
Toshiba’s Aplio 500 Platinum ultrasound system provides powerful clinical imaging technology for advanced visualization, quantification and intervention. Both the Aplio 500 Platinum and Aplio 300 Platinum offer a comprehensive contrast imaging package that allows clinicians to assess perfusion dynamics in a wide range of clinical settings.
For more information: www.medical.toshiba.com